We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EU Provides BioNTech $113 Million to Develop COVID-19 Vaccine
EU Provides BioNTech $113 Million to Develop COVID-19 Vaccine
The European Investment Bank is making available up to $113 million in financing for BioNTech’s BNT162, a messenger RNA-based vaccine, and the scaling up of manufacturing capacity for it in Europe.